Canada Pension Plan Investment Board
KROS icon

Canada Pension Plan Investment Board’s Keros Therapeutics KROS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247K Sell
23,100
-21,000
-48% -$234K ﹤0.01% 1536
2026
Q1 		$487K Hold
44,100
– – ﹤0.01% 1239
2025
Q4 		$898K Sell
44,100
-183,200
-81% -$3.21M ﹤0.01% 1103
2025
Q3 		$3.6M Sell
227,300
-91,100
-29% -$1.35M ﹤0.01% 807
2025
Q2 		$4.25M Buy
+318,400
New +$4.3M ﹤0.01% 734

Other funds holding KROS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Canada Pension Plan Investment Board's KROS Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Keros Therapeutics (KROS) stake by 48% in Q2 2026, selling an estimated $234K and leaving 23,100 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.

Canada Pension Plan Investment Board first reported a position in KROS in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.25M in Q2 2025. 132 funds tracked by Wall St. Rank hold KROS as of Q2 2026.

  • Canada Pension Plan Investment Board held 23,100 shares of Keros Therapeutics worth $247K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 21,000 Keros Therapeutics shares in Q2 2026, an estimated $234K.
  • Keros Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1536 holding.
  • Canada Pension Plan Investment Board first reported a position in Keros Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Canada Pension Plan Investment Board's Keros Therapeutics position peaked at $4.25M in Q2 2025.
  • 132 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.